1. Home
  2. SPCB vs FGEN Comparison

SPCB vs FGEN Comparison

Compare SPCB & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • FGEN
  • Stock Information
  • Founded
  • SPCB 1988
  • FGEN 1993
  • Country
  • SPCB Israel
  • FGEN United States
  • Employees
  • SPCB N/A
  • FGEN N/A
  • Industry
  • SPCB Semiconductors
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • FGEN Health Care
  • Exchange
  • SPCB Nasdaq
  • FGEN Nasdaq
  • Market Cap
  • SPCB 31.4M
  • FGEN 34.5M
  • IPO Year
  • SPCB N/A
  • FGEN 2014
  • Fundamental
  • Price
  • SPCB $8.80
  • FGEN $0.50
  • Analyst Decision
  • SPCB Strong Buy
  • FGEN
  • Analyst Count
  • SPCB 1
  • FGEN 0
  • Target Price
  • SPCB $18.00
  • FGEN N/A
  • AVG Volume (30 Days)
  • SPCB 774.9K
  • FGEN 885.8K
  • Earning Date
  • SPCB 11-14-2024
  • FGEN 02-24-2025
  • Dividend Yield
  • SPCB N/A
  • FGEN N/A
  • EPS Growth
  • SPCB N/A
  • FGEN N/A
  • EPS
  • SPCB 1.02
  • FGEN N/A
  • Revenue
  • SPCB $26,843,000.00
  • FGEN $180,015,000.00
  • Revenue This Year
  • SPCB $6.72
  • FGEN $21.91
  • Revenue Next Year
  • SPCB $16.91
  • FGEN N/A
  • P/E Ratio
  • SPCB $8.59
  • FGEN N/A
  • Revenue Growth
  • SPCB 5.23
  • FGEN 16.15
  • 52 Week Low
  • SPCB $2.55
  • FGEN $0.18
  • 52 Week High
  • SPCB $18.95
  • FGEN $2.93
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 46.90
  • FGEN 49.50
  • Support Level
  • SPCB $9.21
  • FGEN $0.46
  • Resistance Level
  • SPCB $11.43
  • FGEN $0.51
  • Average True Range (ATR)
  • SPCB 1.74
  • FGEN 0.05
  • MACD
  • SPCB -0.67
  • FGEN -0.01
  • Stochastic Oscillator
  • SPCB 1.64
  • FGEN 31.25

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Share on Social Networks: